182 related articles for article (PubMed ID: 21345642)
1. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
Josephson CD; Castillejo MI; Caliendo AM; Waller EK; Zimring J; Easley KA; Kutner M; Hillyer CD; Roback JD
Transfus Med Rev; 2011 Apr; 25(2):125-32. PubMed ID: 21345642
[TBL] [Abstract][Full Text] [Related]
2. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study.
Josephson CD; Caliendo AM; Easley KA; Knezevic A; Shenvi N; Hinkes MT; Patel RM; Hillyer CD; Roback JD
JAMA Pediatr; 2014 Nov; 168(11):1054-62. PubMed ID: 25243446
[TBL] [Abstract][Full Text] [Related]
3. Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy.
Delaney M; Mayock D; Knezevic A; Norby-Slycord C; Kleine E; Patel R; Easley K; Josephson C
Transfusion; 2016 Aug; 56(8):1945-50. PubMed ID: 27080192
[TBL] [Abstract][Full Text] [Related]
4. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
Weisberg SP; Staley EM; Williams LA; Pham HP; Bachegowda LS; Cheng YH; Schwartz J; Shaz BH
Arch Pathol Lab Med; 2017 Dec; 141(12):1705-1711. PubMed ID: 28849943
[TBL] [Abstract][Full Text] [Related]
5. Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.
Shigemura T; Yanagisawa R; Komori K; Morita D; Kurata T; Tanaka M; Sakashita K; Nakazawa Y
Transfusion; 2019 Oct; 59(10):3065-3070. PubMed ID: 31322734
[TBL] [Abstract][Full Text] [Related]
6. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products.
Nichols WG; Price TH; Gooley T; Corey L; Boeckh M
Blood; 2003 May; 101(10):4195-200. PubMed ID: 12531791
[TBL] [Abstract][Full Text] [Related]
8. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
[TBL] [Abstract][Full Text] [Related]
9. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
Yeager AS; Grumet FC; Hafleigh EB; Arvin AM; Bradley JS; Prober CG
J Pediatr; 1981 Feb; 98(2):281-7. PubMed ID: 6257877
[TBL] [Abstract][Full Text] [Related]
10. AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections.
; Heddle NM; Boeckh M; Grossman B; Jacobson J; Kleinman S; Tobian AA; Webert K; Wong EC; Roback JD
Transfusion; 2016 Jun; 56(6 Pt 2):1581-7. PubMed ID: 26968400
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infections in neonates acquired by blood transfusions.
Adler SP; Chandrika T; Lawrence L; Baggett J
Pediatr Infect Dis; 1983; 2(2):114-8. PubMed ID: 6304663
[TBL] [Abstract][Full Text] [Related]
12. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187
[TBL] [Abstract][Full Text] [Related]
13. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
[TBL] [Abstract][Full Text] [Related]
14. Prevention of transfusion-transmitted cytomegalovirus infection.
Pamphilon DH; Rider JR; Barbara JA; Williamson LM
Transfus Med; 1999 Jun; 9(2):115-23. PubMed ID: 10354380
[TBL] [Abstract][Full Text] [Related]
15. Transfusion-associated cytomegalovirus infections.
Adler SP
Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a prescreening blood donor program for prevention of perinatal transfusion-acquired cytomegalovirus (CMV) infection.
Bhumbra NA; Lewandowski P; Lau P; Sererat M; Satish M; Nankervis GA
J Perinat Med; 1988; 16(2):127-31. PubMed ID: 2845045
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-acquired cytomegalovirus infection in neonates. A prospective study.
Preiksaitis JK; Brown L; McKenzie M
Transfusion; 1988; 28(3):205-9. PubMed ID: 2835838
[TBL] [Abstract][Full Text] [Related]
18. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
Gilbert GL; Hayes K; Hudson IL; James J
Lancet; 1989 Jun; 1(8649):1228-31. PubMed ID: 2566781
[TBL] [Abstract][Full Text] [Related]
19. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood.
Eisenfeld L; Silver H; McLaughlin J; Klevjer-Anderson P; Mayo D; Anderson J; Herson V; Krause P; Savidakis J; Lazar A
Transfusion; 1992; 32(3):205-9. PubMed ID: 1313609
[TBL] [Abstract][Full Text] [Related]
20. Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates.
Snydman DR; Werner BG; Meissner HC; Cheeseman SH; Schwab J; Bednarek F; Kennedy JL; Herschel M; Magno A; Levin MJ
Pediatr Infect Dis J; 1995 Jan; 14(1):34-40. PubMed ID: 7715987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
